46.46.Z - Wholesale trade of pharmaceutical and medical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
46.51.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
62.01.Z - Activities related to programming, IT consulting, and related activities
62.02.Z - Activities related to programming, IT consulting, and related activities
62.09.Z - Activities related to programming, IT consulting, and related activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0,1 | 0 | -88,2 |
EBITDA | 0,1 | 0,1 | 0 | -73,7 |
Short time liabilities | 0,2 | 0,5 | 0,4 | -8,6 |
Equity capital | 0,9 | 0,9 | 0,9 | 0,2 |
Operating profit (EBIT) | 0,1 | 0,1 | 0 | -73,4 |
Assets | 1,6 | 1,9 | 1,9 | 1,5 |
Net profit (loss) | 0 | 0,1 | 0 | -95,7 |
Cash | 0 | 0,2 | 0,1 | -29,7 |
Liabilities and provisions for liabilities | 0,7 | 1 | 1 | 2,7 |
Net income from sale | 1,7 | 2,3 | 1,9 | -16,9 |
Working assets | 1,6 | 1,9 | 1,9 | 1,5 |
Depreciation | 0 | 0 | 0 | -82,9 |
% | % | % | p.p. | |
Profitability of capital | 3,7 | 5,6 | 0,2 | -5,4 |
Equity capital to total assets | 55,3 | 49,3 | 48,7 | -0,6 |
Gross profit margin | 2 | 2,6 | 0,4 | -2,2 |
EBITDA Margin | 4 | 4,5 | 1,4 | -3,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 53 | 76 | 84 | 8 |
Current financial liquidity indicator | 6.3482866287231445 | 3.934854745864868 | 4.369521141052246 | 0,5 |
Net dept to EBITDA | 7.1640214920043945 | 2.801124095916748 | 16.302589416503906 | 13,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane